• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Probiotic supplementation may improve outcomes in patients with type 2 diabetes

byAlex Chan
January 14, 2024
in Cardiology, Chronic Disease, Endocrinology, Gastroenterology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Patients with type 2 diabetes randomized to using probiotic supplements were found to have significantly reduced lipoprotein-associated phospholipase A2 levels at 12-weeks follow-up. 

2. Probiotic supplementation was also associated with improved glycemic control at follow-up. 

Evidence Level Rating: 1 (Excellent)

Type 2 diabetes affects many adults worldwide and is increasing in prevalence in many countries. In patients experiencing type 2 diabetes, it has been hypothesized that inflammatory markers such as lipoprotein-associated phospholipase A2 increase the risk of cardiovascular events. In this double-blind randomized controlled trial based in Iraq, 68 participants with a type 2 diabetes diagnosis, aged 50-65 years were assigned to either receive a probiotic supplement or a placebo pill. The goal was to determine whether probiotic supplementation would result in reduced lipoprotein-associated phospholipase A2 levels, as well as improved glycemic control at 12-weeks follow-up. Included in the probiotic supplement were Bacillus Coagulans, Lactobacillus plantarum, Lactobacillus acidophilus and Bifidobacterium bifdum. At follow-up, there was noted to be a statistically significant reduction in lipoprotein-associated phospholipase A2 levels in patients taking probiotics, in addition to a positive impact on HBa1c and high-density lipoprotein cholesterol levels. One of the limitations of the study was the short timeframe in which it was conducted, as diabetes complications tend to accumulate over longer timeframes. Additionally, this study could have used a food record instead of a food recall to create a more accurate response. Overall, the study findings indicate that there may be a role for probiotics in the improvement of outcomes for patients with type 2 diabetes. With further research in the area, practitioners may consider including probiotics as a counseling point for diabetes education. 

Click to read the study in Nutrition and Metabolism

Image: PD

RELATED REPORTS

Weekly basal insulin efsitora effective for managing type 2 diabetes

Intensive systolic blood pressure targets may be cost-effective across most measurement error possibilities

Increased Serum 25(OH)D levels associated with decreased mortality risk in adult men

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

Tags: cardiovascular diseasecardiovascular riskdiabetesinflammationnutritionprobiotics
Previous Post

Low dose prenatal tobacco and alcohol result in long lasting changes on electroencephalogram

Next Post

2 Minute Medicine Rewind January 15, 2024

RelatedReports

Dual VA and Medicare coverage linked to glucose strip overuse
Cardiology

Weekly basal insulin efsitora effective for managing type 2 diabetes

August 27, 2025
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Intensive systolic blood pressure targets may be cost-effective across most measurement error possibilities

August 22, 2025
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Chronic Disease

Increased Serum 25(OH)D levels associated with decreased mortality risk in adult men

August 2, 2025
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Cardiology

Bedtime dosing of antihypertensive medications may provide improved outcomes over morning dosing

July 24, 2025
Next Post
Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

2 Minute Medicine Rewind January 15, 2024

Higher pre-pregnancy BMI linked to adverse adolescent cardio-metabolic profile

Curcumin-piperine supplementation may lead to lower inflammation in post-stroke patients

No clinical benefit of specific immunotherapy seen in lymphoma

Prolonged rituximab maintenance therapy does not provide overall survival benefit in low-burden follicular lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Significant body weight reduction with cagrilintide-semaglutide therapy
  • Machine learning models diagnose celiac disease at similar performance levels to pathologists
  • Presymptomatic treatment of spinal muscular atrophy with risdiplam leads to improved functional outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.